YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2026	Characterization of Pana g 1, an important cause of pollen-food allergy syndrome from Korean ginseng, Panax ginseng	WORLD ALLERGY ORGANIZATION JOURNAL
2026	Bisphosphonates as a Tacrolimus-Sparing Strategy in Kidney Transplantation: Insights from a Retrospective Analysis	YONSEI MEDICAL JOURNAL
2025	Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific region	JOURNAL OF MEDICAL ECONOMICS
2025	Treatment of older patients with Hodgkin lymphoma	BLOOD RESEARCH
2025	First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial	EUROPEAN JOURNAL OF CANCER
2025	Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study	LUNG CANCER
2025	Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study	DIABETES THERAPY
2025	The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2025	Trends in Health Expenditures for Chronic Disease Management: Hypertension, Diabetes Mellitus, and Dyslipidemia from 2013 to 2020	YONSEI MEDICAL JOURNAL
2025	Quality Matters: Effect of High-Quality Early Palliative Care in Advanced Cancer	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2025	Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study	ORAL ONCOLOGY
2025	The impact of the COVID-19 pandemic on chronic lymphocytic thyroiditis: A single-center retrospective analysis	JOURNAL OF INFECTION AND PUBLIC HEALTH
2025	Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial	NATURE MEDICINE
2025	Utility of serum cystatin C measured at diagnosis in evaluating cross-sectional activity and predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis	CLINICAL RHEUMATOLOGY
2025	Low levels of serum albumin and blood basophils as 10-year mortality predictors in a nationwide Korean COPD cohort	SCIENTIFIC REPORTS
2025	Reducing False Alarm Rates and Workload in ICUs by Improving Arrhythmia Detection Algorithms of Patient Monitoring Systems	MEDICAL SCIENCE MONITOR
2025	A Response to the Letter to the Editor: "Comparable or Indeterminate? A Critical Appraisal of Efficacy Claims in the MARIPOSA Exploratory Analysis	JOURNAL OF THORACIC ONCOLOGY
2025	Xenograft-Derived Cell-Free Deoxyribonucleic Acid as an Early Biomarker of Rejection in Genetically Engineered Pig-to-Non-Human Primate Kidney Xenotransplantation	XENOTRANSPLANTATION
2025	Empagliflozin and Dapagliflozin Outcomes in Heart Failure	JAMA NETWORK OPEN
2025	Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study	ESMO OPEN